Literature DB >> 26409637

Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort study).

Juan E Grunwald1, Maxwell Pistilli2, Gui-Shuang Ying2, Maureen Maguire2, Ebenezer Daniel2, Revell Whittock-Martin2, Candace Parker-Ostroff2, Emile Mohler2, Joan C Lo3, Raymond R Townsend2, Crystal Ann Gadegbeku4, James Phillip Lash5, Jeffrey Craig Fink6, Mahboob Rahman7, Harold Feldman2, John W Kusek8, Dawei Xie2.   

Abstract

Patients with chronic kidney disease (CKD) experience other diseases such as cardiovascular disease (CVD) and retinopathy. The purpose of this study was to assess whether retinopathy predicts future CVD events in a subgroup of the participants of the Chronic Renal Insufficiency Cohort (CRIC) study. In this ancillary investigation, 2,605 participants of the CRIC study were invited to participate, and nonmydriatic fundus photographs were obtained in 1,936 subjects. Using standard protocols, presence and severity of retinopathy (diabetic, hypertensive, or other) and vessel diameter caliber were assessed at a central photograph reading center by trained graders masked to study participant's information. Patients with a self-reported history of cardiovascular disease were excluded. Incident CVD events were adjudicated using medical records. Kidney function measurements, traditional and nontraditional risk factors, for CVD were obtained. Presence and severity of retinopathy were associated with increased risk of development of any CVD in this population of CKD patients, and these associations persisted after adjustment for traditional risk factors for CVD. We also found a direct relation between increased venular diameter and risk of development of CVD; however, the relation was not statistically significant after adjustment for traditional risk factors. In conclusion, the presence of retinopathy was associated with future CVD events, suggesting that retinovascular pathology may be indicative of macrovascular disease even after adjustment for renal dysfunction and traditional CVD risk factors. Assessment of retinal morphology may be valuable in assessing risk of CVD in patients with CKD, both clinically and in research settings.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26409637      PMCID: PMC4630087          DOI: 10.1016/j.amjcard.2015.08.015

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

1.  Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study.

Authors:  L D Hubbard; R J Brothers; W N King; L X Clegg; R Klein; L S Cooper; A R Sharrett; M D Davis; J Cai
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

Review 2.  Retinal signs and stroke: revisiting the link between the eye and brain.

Authors:  Michelle L Baker; Peter J Hand; Jie Jin Wang; Tien Y Wong
Journal:  Stroke       Date:  2008-02-28       Impact factor: 7.914

3.  Retinal vessel diameters and risk of stroke: the Rotterdam Study.

Authors:  M K Ikram; F J de Jong; M J Bos; J R Vingerling; A Hofman; P J Koudstaal; P T V M de Jong; M M B Breteler
Journal:  Neurology       Date:  2006-05-09       Impact factor: 9.910

4.  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1991-05       Impact factor: 12.079

5.  Quantitative retinal venular caliber and risk of cardiovascular disease in older persons: the cardiovascular health study.

Authors:  Tien Yin Wong; Aruna Kamineni; Ronald Klein; A Richey Sharrett; Barbara E Klein; David S Siscovick; Mary Cushman; Bruce B Duncan
Journal:  Arch Intern Med       Date:  2006-11-27

6.  Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study.

Authors:  M Kamran Ikram; Joop A M J L Janssen; Anna M E Roos; Ingrid Rietveld; Jacqueline C M Witteman; Monique M B Breteler; Albert Hofman; Cornelia M van Duijn; Paulus T V M de Jong
Journal:  Diabetes       Date:  2006-02       Impact factor: 9.461

7.  Retinopathy predicts coronary heart disease mortality.

Authors:  G Liew; T Y Wong; P Mitchell; N Cheung; J J Wang
Journal:  Heart       Date:  2008-08-12       Impact factor: 5.994

8.  Diabetic retinopathy in a multi-ethnic cohort in the United States.

Authors:  Tien Yin Wong; Ronald Klein; F M Amirul Islam; Mary Frances Cotch; Aaron R Folsom; Barbara E K Klein; A Richey Sharrett; Steven Shea
Journal:  Am J Ophthalmol       Date:  2006-03       Impact factor: 5.258

9.  The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.

Authors:  Harold I Feldman; Lawrence J Appel; Glenn M Chertow; Denise Cifelli; Borut Cizman; John Daugirdas; Jeffrey C Fink; Eunice D Franklin-Becker; Alan S Go; L Lee Hamm; Jiang He; Tom Hostetter; Chi-Yuan Hsu; Kenneth Jamerson; Marshall Joffe; John W Kusek; J Richard Landis; James P Lash; Edgar R Miller; Emile R Mohler; Paul Muntner; Akinlolu O Ojo; Mahboob Rahman; Raymond R Townsend; Jackson T Wright
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

10.  Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.

Authors:  James P Lash; Alan S Go; Lawrence J Appel; Jiang He; Akinlolu Ojo; Mahboob Rahman; Raymond R Townsend; Dawei Xie; Denise Cifelli; Janet Cohan; Jeffrey C Fink; Michael J Fischer; Crystal Gadegbeku; L Lee Hamm; John W Kusek; J Richard Landis; Andrew Narva; Nancy Robinson; Valerie Teal; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

View more
  5 in total

1.  Association Between Progression of Retinopathy and Concurrent Progression of Kidney Disease: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Ebenezer Daniel; Maureen Maguire; Dawei Xie; Jason Roy; Revell Whittock-Martin; Candace Parker Ostroff; Joan C Lo; Raymond R Townsend; Crystal A Gadegbeku; James P Lash; Jeffrey C Fink; Mahboob Rahman; Harold I Feldman; John W Kusek
Journal:  JAMA Ophthalmol       Date:  2019-07-01       Impact factor: 7.389

Review 2.  Psoriasis as a human model of disease to study inflammatory atherogenesis.

Authors:  Charlotte L Harrington; Amit K Dey; Raza Yunus; Aditya A Joshi; Nehal N Mehta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-03       Impact factor: 4.733

3.  Progression of retinopathy and incidence of cardiovascular disease: findings from the Chronic Renal Insufficiency Cohort Study.

Authors:  Juan E Grunwald; Maxwell Pistilli; Gui-Shuang Ying; Maureen G Maguire; Ebenezer Daniel; Revell Whittock-Martin; Candace Parker-Ostroff; Douglas Jacoby; Alan S Go; Raymond R Townsend; Crystal Ann Gadegbeku; James P Lash; Jeffrey Craig Fink; Mahboob Rahman; Harold Feldman; John W Kusek; Dawei Xie
Journal:  Br J Ophthalmol       Date:  2020-06-05       Impact factor: 4.638

4.  Vitamin D and retinal microvascular damage: The Rotterdam Study.

Authors:  Unal Mutlu; M Arfan Ikram; Albert Hofman; Paulus T V M de Jong; Andre G Uitterlinden; Caroline C W Klaver; M Kamran Ikram
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

5.  Effects of retinopathy and chronic kidney disease on long-term mortality in type 2 diabetic inpatients with normal urinary albumin or protein: a retrospective cohort study.

Authors:  Yu-Hsuan Li; Wayne H-H Sheu; I-Te Lee
Journal:  BMJ Open       Date:  2018-07-25       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.